Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics | $5.88 | -$7.79 | -56.99% | 4.6M | $99M | $5.01$19.15 |
| LYRA | Lyra Therapeutics | $2.06 | -$1.71 | -45.31% | 1.4M | $6.7M | $1.63$37.50 |
| LXEO | Lexeo Therapeutics | $8.12 | -$2.42 | -22.96% | 5.2M | $769M | $1.45$10.99 |
| ATEC | Alphatec | $17.59 | -$5.06 | -22.34% | 13.6M | $3.4B | $8.81$23.29 |
| THH | TryHard | $23.10 | -$6.37 | -21.61% | 183.4K | $1.5B | $4.00$30.52 |
| DGNX | Diginex | $2.42 | -$0.66 | -21.43% | 2.6M | $622M | $0.45$39.85 |
| NUVB | Nuvation Bio | $6.46 | -$1.58 | -19.65% | 15.6M | $2.8B | $1.54$9.75 |
| CLNN | Clene | $5.18 | -$1.22 | -19.00% | 359.9K | $66M | $2.28$13.50 |
| SEV | Aptera Motors | $3.99 | -$0.90 | -18.41% | 466.3K | $135M | $3.55$40.85 |
| AZI | Autozi Internet Technology (Global) | $2.62 | -$0.57 | -17.87% | 438K | $326M | $1.33$69.00 |
Related Articles
Featured Article
2 Stocks Up Over 600% in the Past 3 Years With More Room to Run
Prosper Junior Bakiny|Dec 9, 2025
They haven't peaked yet.
Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now?
David Jagielski, CPA|Dec 5, 2025
The healthcare stock could skyrocket if ivonescimab obtains approval from regulators, but there's still plenty of risk here.
Don't Buy Summit Therapeutics Until This Big Thing Happen
Keith Speights|Dec 3, 2025
This biotech company is rolling the dice with a planned regulatory submission.
Advertisement
1 Monster Stock in the Making to Buy and Hold
Prosper Junior Bakiny|Oct 27, 2025
The company's prospects improve with every clinical win.
1 Monster Stock in the Making to Buy and Hold
Prosper Junior Bakiny|Oct 5, 2025
This biotech company was relatively unknown a few years ago.
Is Summit Therapeutics a Buy, Sell, or Hold Now?
Cory Renauer|Sep 9, 2025
Western results for ivonescimab aren't lining up with the huge survival benefit measured in China.
This Healthcare Stock's Revolutionary Drug Could Make Early Investors Rich
Prosper Junior Bakiny|Jul 21, 2025
